X
X

Tom O'Brien

CEO

Prior to founding Eclipse in 1993, Tom held several leadership positions throughout his career in the medical device industry. Having mastered both disposable and capital equipment sales for companies like C.R. Bard, Tom’s track record of success quickly established Eclipse as the go-to company to launch new technology in the surgical laser industry.

Over time Tom transitioned Eclipse from a leader in the OR surgical laser market to a key player in the aesthetic laser industry. Starting in 2011 Eclipse began a new mission of increasing adoption of Platelet-rich Plasma on a national level.

His vision and leadership has helped Eclipse become one of the most successful medical device companies in its space. Tom’s new mission is to bring game-changing Eclipse technologies in Platelet-Rich Plasma, Microneedling and Shockwave Therapy to the entire globe.

X

BLOG

Learn more about what is happening at Eclipse and how we are keeping the industry on its toes.

Keep Your Hair Loss Patients Successful at Home with Votesse and Theradome

Posted by Eclipse Med on Apr 14, 2020

Votesse April Art

As we continue to monitor the situation with Coronavirus (COVID-19), we are taking steps to help protect the health and well-being of our customers and their patients.

For most people across the country, we’re in the midst of an extended, mandatory shelter in place order from local governments. Dermatology and aesthetics practices have answered the call to help “flatten the curve” by shutting down their aesthetic services and donating their PPE to emergency medicine personnel on the frontlines of the COVID-19 pandemic; a noble way to help in the fight.

In addition to the added stress and anxiety from the economic and public health circumstances, hair-loss patients around the country are likely worried about losing the results they gained from in-office procedures. This could be a legitimate concern since the majority of proven protocols for hair loss require established, monthly treatments* — now indefinitely suspended due to the virus.

While those not needing treatment may argue medical hair-loss is a “non-essential” category, losing your hair can take a psychological toll on an individual. Scientific literature has shown this is indeed a quality of life issue**.

This new reality can leave both patients and providers feeling helpless, but it doesn’t have to be that way.

Since 2016, Eclipse has been on the forefront of teaching physicians how to help their patients fight hair loss with non-surgical combination therapies. Those of you trained by our KOLs learned that hair loss is multi-factorial and no single modality offers a “silver bullet” solution.

Our professional home-use products are made for this unique “home therapy” situation. Oral and topical nutraceuticals, as well as low-level light therapy (LLLT) are key components of our “kitchen sink” approach to getting (and keeping!) healthy hair.

“For a limited time Eclipse is offering drop shipping to patients on home-use products like Votesse and Theradome.”

Both Votesse™ and Theradome™ were designed to complement professional procedures at home with proven methods that boost results and put additional profit into your practice. These products are especially helpful now, as potentially the only way to stay connected with your hair health patients and keep revenue flowing in the absence of in-office procedures.

We can support your business today by helping you stay connected with your patients through the use of Votesse™ and Theradome™, and we can help increase your profitability tomorrow with our aggressive sales specials.

Today through 4/27/2020, when you purchase a Votesse Starter Package, you’ll get a Theradome for FREE. That’s a $900 retail value product you can provide to your patients to use at home.

We’re also establishing a new added benefit to Eclipse PRP customers with bundle discounts. Moving forward, all current Eclipse PRP customers who reorder a minimum of 12 Votesse with 12 Eclipse PRP kits can take an extra 5% off their entire order.

If you would like to have Votesse shipped directly to your patients, or have competitive nutraceutical product to trade-in, we’ll gladly connect you with one of our representatives around the country. Please contact us at 800-759-6876, email us at info@eclipsemed.com or reach out to your local Eclipse representative to take advantage of this offer.

Follow us on social media, tag and post about us with #EclipsePRP #Votesse #EclipseMicropen #eVive

Instagram: Eclipse_Med; eclipseprp

Twitter: EclipseMed

Facebook: EclipseMedCorp

Here’s to a bright future!

– The Eclipse Team

 

* Dermatol Surg. 2018 Sep;44(9):1191-1200. doi: 10.1097/DSS.0000000000001567. Evaluating the Efficacy of Different Platelet-Rich Plasma Regimens for Management of Androgenetic Alopecia: A Single-Center, Blinded, Randomized Clinical Trial. Hausauer AK1,2, Jones DH2,3.

** Int J Womens Dermatol. 2018 Mar; 4(1): 18–22. 2018 Jan 9. doi: 10.1016/j.ijwd.2017.11.007 Review of quality of life studies in women with alopecia. D.S. Davis, MD, MS⁎ and V.D. Callender, MD

Call Toll Free 1-800-759-6876

©2020 Eclipse, All rights reserved